Elizabeth Volkmann
And Director of the CTD-ILD Program · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · · · ·
History
PresentUCLA Scleroderma Center · UCLA David Geffen School of Medicine/UCLA Medical Center
2006–2010- 2004–2008
Research
Review · Arthritis Care & Research · 2012 · 1,232 citations
The Lancet Respiratory Medicine · 2016 · 831 citations
Review · The Lancet · 2023 · First of 3 authors · Corresponding · 499 citations
40 papers
34 papers
27 papers
25 papers
25 papers
24 papers
24 papers
19 papers
Grants
- 2025–2030
Functional Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.4M · University of California Los Angeles
- 2020–2026
Identifying Predictors of Treatment Response in Systemic Sclerosis-Related Interstitial Lung Disease
National Heart, Lung, and Blood Institute · K23
Contact PI · $910.3K · University of California Los Angeles
Clinical trials
- 2026–2028
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Site PI · Recruiting · Phase 2
Mediar Therapeutics
- 2023–2029
Site PI · Recruiting · Phase 2, Phase 3
GlaxoSmithKline